obesity drug news today october 2025 glp-1 WHO Decision Recognizing as a Disease Treatable with Drugs Is “Big Deal,” says BU Endocrinologist | BU glp-1 news 2025 october 9

L-,

Stomach or gastrointestinal side effects are common, but they tend to be mild and clear up in a few weeks and usually will not interfere with long-term treatment

That means any employee who wants a plan that covers GLP-1s can do the research to find the best option on the marketplace, without it impacting the cost of health benefits for the rest of your team

We look forward to helping you feel energized and confident

Resveratrol may protect testicular function by activating sirtuin 1 (SIRT1), thereby exerting antioxidant and anti-apoptotic effects (Zhang X

Bone density decreases as men age and testosterone levels drop